Home
National Cancer Center

National Cancer Center Market Share Analysis for November 2025

国立がん研究センター東病院のホームページです。

Health > Medicine

Domainncc.go.jp

Year Founded1962

Employees1001 - 5000

Annual Revenue--

National Cancer Center

National Cancer Center (including company regionals)

ncc.go.jp

See more website traffic and engagement information

Total visits to National Cancer Center's top domains

Understand National Cancer Center market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ncc.go.jp835.8K

See more with Sales Intelligence

Avg. visit duration in National Cancer Center's top domains

Analyze National Cancer Center engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ncc.go.jp00:02:28

See more with Sales Intelligence

Avg. pageviews on National Cancer Center's top domains

See how National Cancer Center keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ncc.go.jp2.45

See more with Sales Intelligence

National Cancer Center top competitors by domain

Top similar sites in November 2025, ranked by their affinity

jfcr.or.jpCompany NameJapanese Foundation for Cancer ResearchEmployees1001 - 5000HQJapan, TokyoAnnual revenue--Total visits193.5KHealth > Medicine

Top technologies used by National Cancer Center

These are the website technologies, by industry, used by National Cancer Center top domains

Social (7)

Instagram

Email Services (4)

Microsoft Exchange Online

Conversion & Analytics (3)

Google Analytics

Advertising (2)

DoubleClick

More Technologies

5

See all

News & Signals from National Cancer Center

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLunit Inc. partnered with National Cancer Center on May 1st '23.Lunit recently announced a collaboration with the National Cancer Centre Hospital East (NCCHE) to assess and authenticate its AI pathology solution for analysing tissue data.

NewsPersonalis, Inc. partnered with National Cancer Center on May 16th '23.Personalis said Tuesday that it has partnered with Ono Pharmaceutical and Japan's National Cancer Center to assess its minimal residual disease platform in a study of Opdivo (nivolumab) in resectable rectal cancer with mismatch repair deficiency.

NewsNational Cancer Center launched LC-SCRUM-Asia as LC-SCRUM-Japan on Jan 1st '13.The National Cancer Center Hospital East initially launched LC-SCRUM-Asia as LC-SCRUM-Japan in 2013.